Literature DB >> 6436226

Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin.

J Y Jacobs, D M Livermore, K W Davy.   

Abstract

Azlocillin, mezlocillin and piperacillin are weak substrates for the chromosomal beta-lactamase of Pseudomonas aeruginosa, and hydrolysis kinetics were calculated. Enzyme function in the living cell was studied by comparing antibiotic activity against a typical Ps. aeruginosa strain with inducible beta-lactamase expression with antibiotic activity against beta-lactamase uninducible and constitutive mutants. The inducible organism was less sensitive than its uninducible mutant to all three agents; this difference was more apparent at high inocula than low and in broth than in agar. These differences involved both enzyme induction and selection of genotypically enzyme derepressed variants. The penicillins were not, however, efficient beta-lactamase inducers at low concentrations and their activity against the inducible organism was antagonized by more potent inducers. Secondary inducers did not antagonize antibiotic activity against beta-lactamase uninducible and constitutive organisms. The beta-lactamase constitutive mutants were highly resistant to the three antibiotics tested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436226     DOI: 10.1093/jac/14.3.221

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Evidence for multiple forms of type I chromosomal beta-lactamase in Pseudomonas aeruginosa.

Authors:  M L Gates; C C Sanders; R V Goering; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 2.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression.

Authors:  T Y Langaee; L Gagnon; A Huletsky
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Ability of newer beta-lactam antibiotics to induce beta-lactamase production in Enterobacter cloacae.

Authors:  R L Then
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 5.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Beta-lactamase alteration of beta-lactam inhibitory zones.

Authors:  F Tausk; C W Stratton
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 7.  Microbiological investigation of cephalosporins.

Authors:  J M Hamilton-Miller
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 8.  Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.

Authors:  D M Livermore
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

9.  Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa.

Authors:  C C Sanders; M L Gates; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.